319 results on '"Nathanson, N"'
Search Results
2. Primary demyelination in visna: An ultrastructural study of Icelandic sheep with clinical signs following experimental infection
3. An ultrastructural study of the cerebrospinal fluid in visna
4. Molecular Properties of the Muscarinic Acetylcholine Receptor.
5. The genetics of susceptibility to multiple sclerosis.
6. Genetic determinants of virus susceptibility: epidemiologic implications of murine models.
7. FATAL JAPANESE ENCEPHALITIS VIRUS INFECTION IN IMMUNOSUPPRESSED SPIDER MONKEYS.
8. Detection of viral genes and their products in chronic neurological diseases.
9. Precipitating antibodies in experimental visna and natural progressive pneumonia of sheep
10. The effect of post-infection immunization on the severity of experimental visna
11. Experimental visna in foetal Icelandic sheep
12. Isolation, sequence, and functional expression of the mouse M1 muscarinic acetylcholine receptor gene.
13. Regulation of cAMP-mediated gene transcription by wild type and mutated G-protein alpha subunits. Inhibition of adenylyl cyclase activity by muscarinic receptor-activated and constitutively activated G(o) alpha.
14. Regulation by High Density Lipoproteins of Muscarinic Acetylcholine Receptor Function in Chick Heart Cells Cultured in Defined Medium
15. Differential tissue expression and developmental regulation of guanine nucleotide binding regulatory proteins and their messenger RNAs in rat heart.
16. Pathogenesis of type 1 dengue virus infection in suckling, weaned and adult mice: II. Immunofluorescent and histological studies
17. Eastern equine encephalitis: Distribution of central nervous system lesions in man and rhesus monkey
18. Comparative Pathogenesis of Virulent and Avirulent California Encephalitis Viruses.
19. STUDIES ON THE IMMUNOLOGIC CLEARANCE OF EXPERIMENTAL RABIES IN MICE.
20. PATHOGENESIS OF VISINA. I. SEQUENTIAL VIROLOGICAL, IMMUNOLOGICAL, AND PATHOLOGICAL OBSERVATIONS.
21. PATHOGENESIS OF VISNA. II. EFFECT OF IMMUNOSUPPRESSION UPON EARLY CENTRAL NERVOUS SYSTEM LESIONS.
22. Neurovirulence of California Encephalitis Viruses Is Under Polygenic Control.
23. The A.R.M. Decision.
24. La crosse bunyavirus can mediate pH-dependent fusion from without
25. Activation of protein kinase C induces rapid internalization and subsequent degradation of muscarinic acetylcholine receptors in neuroblastoma cells.
26. Cloning and functional analysis of a gene encoding a novel muscarinic acetylcholine receptor expressed in chick heart and brain.
27. Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor. Analysis of the role of N-glycosylation in receptor expression and function.
28. Role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells
29. [COMPREHENSIVE GUIDELINES AND INDICATIONS FOR DIGITAL MONITORING OF PATIENTS AT HIGH-RISK FOR MELANOMA: A POSITION PAPER BY THE ISRAELI ASSOCIATION FOR DERMATOLOGY].
30. Metamorphosis: The American Journal of Hygiene Becomes the American Journal of Epidemiology.
31. Pathogenic Events in a Nonhuman Primate Model of Oral Poliovirus Infection Leading to Paralytic Poliomyelitis.
32. Training tomorrow's leaders in global health: impact of the Afya Bora Consortium Fellowship on the careers of its alumni.
33. HIV/AIDS epidemic: The whole truth.
34. Training tomorrow's global health leaders: applying a transtheoretical model to identify behavior change stages within an intervention for health leadership development.
35. Viral neuropathogenesis.
36. Global health education in U.S. medical schools.
37. Regression of nevi in a melanoma patient treated with interferon.
38. The Afya Bora Consortium: an Africa-US partnership to train leaders in global health.
39. Poliovirus vaccines: past, present, and future.
40. Eradication of poliovirus: fighting fire with fire.
41. From emergence to eradication: the epidemiology of poliomyelitis deconstructed.
42. The pathogenesis of poliomyelitis: what we don't know.
43. Diagnosis and treatment of a perforated duodenal diverticulum.
44. David Bodian's contribution to the development of poliovirus vaccine.
45. Development of an AIDS vaccine: a daunting epidemiological challenge.
46. Virus perpetuation in populations: biological variables that determine persistence or eradication.
47. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
48. Circulating vaccine-derived polioviruses: current state of knowledge.
49. Validity of a decision rule to reduce cervical spine radiography in elderly patients with blunt trauma.
50. Virology. Poliomyelitis eradication--a dangerous endgame.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.